Relationships between the Bone Expression of Alzheimer Disease-Related Genes, Bone Remodelling Genes and Cortical Bone Structure in Neck of Femur Fracture
C. J. M. Stapledon, R. Stamenkov, R. Cappai, J. M. Clark, A. Bourke, L. B. Solomon, G. J. Atkins
Abstract
Neck of femur (NOF) fracture is a prevalent fracture type amongst the ageing and osteoporotic populations, commonly requiring total hip replacement (THR) surgery. Increased fracture risk has also been associated with Alzheimer disease (AD) in the aged. Here, we sought to identify possible relationships between the pathologies of osteoporosis and dementia by analysing bone expression of neurotropic or dementia-related genes in patients undergoing THR surgery for NOF fracture. Femoral bone samples from 66 NOF patients were examined for expression of the neurotropic genes amyloid precursor protein (APP), APP-like protein-2 (APLP2), Beta Secretase Cleaving Enzyme-1 (BACE1) and nerve growth factor (NGF). Relationships were examined between the expression of these and of bone regulatory genes, systemic factors and bone structural parameters ascertained from plain radiographs. We found strong relative levels of expression and positive correlations between APP, APLP2, BACE1 and NGF levels in NOF bone. Significant correlations were found between APP, APLP2, BACE1 mRNA levels and bone remodelling genes TRAP, RANKL, and the RANKL:OPG mRNA ratio, indicative of potential functional relationships at the time of fracture. Analysis of the whole cohort, as well as non-dementia and dementia sub-groups, revealed structural relationships between APP and APLP2 mRNA expression and lateral femoral cortical thickness. These findings suggest that osteoporosis and AD may share common molecular pathways of disease progression, perhaps explaining the common risk factors associated with these diseases. The observation of a potential pathologic role for AD-related genes in bone may also provide alternative treatment strategies for osteoporosis and fracture prevention.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alzheimer's disease risk factor APOE4 exerts dimorphic effects on female bone
Charles A. Schurman, Gurcharan Kaur, … Tamara N. Alliston·Advanced SciencePeer-reviewed·Apr 13, 2026
- Alzheimer's Disease and circadian disruption sex-specifically contribute to a loss of bone maintenance in APP/PS1 model mice
Noah G. Allen, Carmalena V. Cordi, … Elizabeth A. Blaber·bioRxiv·May 5, 2026
- Genetic liability to hip osteoarthritis confers neurovascular protection against Alzheimer's disease despite depression-mediated phenotypic comorbidity
Qi Xu, Pianpian Zhao, … Hou‐Feng Zheng·medRxiv·Mar 4, 2026
- APOE and TREM2 variants differentially influence glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants
Yun Freudenberg‐Hua, Luca Giliberto, … Jeremy L. Koppel·medRxiv·Feb 24, 2025
- Transcriptomic network analysis of brain and bone reveals shared molecular mechanisms underlyingAlzheimer's Disease and related dementias and Osteoporosis
Archana Nagarajan, Jason Laird, … Christine W. Lary·bioRxiv·Oct 26, 2023
- Nociceptin receptor and ligand in Alzheimer's disease:Implications for psychiatric symptoms and circadianregulation
Jonathan S. Vogelgsang, Shantel Gregoy, … Sabina Berretta·bioRxiv·Jun 4, 2025